Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.995 USD | -1.16% | +25.52% | -26.65% |
01:01pm | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
05-10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.65% | 402M | |
+26.49% | 44.96B | |
-0.79% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.52% | 26.08B | |
-21.21% | 19.03B | |
+6.03% | 12.75B | |
+28.51% | 12.06B | |
-3.33% | 11.75B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Morgan Stanley Starts Organogenesis Holdings at Equalweight With $5 Price Target